Drugs / BCG TICE Vaccine
last change Dec 2023 re-read 3 minutes ago

BCG TICE Vaccine

Vaccine

Developed for
pulmonary non-tuberculous mycobacterial infection
Investigated by
Cystic Fibrosis Foundation · Johns Hopkins University

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04884308 Apr 2021 → Dec 2023 bronchiectasis, cystic fibrosis, pulmonary non-tuberculous mycobacterial infection Johns Hopkins University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BCG TICE Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT04884308 ↗
Modality Vaccine “BCG vaccination” NCT04884308 ↗